Parexel chief named ACRO chairman

Parexel ($PRXL) CEO Josef von Rickenbach will serve as chairman of industry group ACRO this year, succeeding PharmaNet CEO Jeffrey McMullen. "As incoming chairman, I look forward to continuing the great momentum initiated by my predecessor to help ACRO and its members build and strengthen public understanding and confidence in clinical research," von Rickenbach said in a statement. More